Search Within

Carl Ola Landgren

Formats
  1. Meeting Abstract (155)
  2. Journal Article (151)
  3. Review (14)
  4. Research Letter (7)
  5. Book Section (3)
  6. Correspondence (2)
  7. Guidelines (2)
  8. Conference Paper (1)
  9. Editorial (1)
Groups
  1. Center for Hematologic Malignancies (336)
  2. Department of Medicine (336)
  3. Hematologic Malignancies Research (336)
  4. Hematologic Malignancies, Division of (336)
  5. Myeloma (336)
  6. Survivorship Research (132)

More Groups

People
  1. Neha Korde (106)
  2. Sham Mailankody (91)
  3. Alexander Lesokhin (83)
  4. Malin Hultcrantz (81)
  5. Hani Hassoun (77)
  6. Sergio Giralt (73)

More People

Years
  1. 2023 (2)
  2. 2022 (4)
  3. 2021 (21)
  4. 2020 (52)
  5. 2019 (56)
  6. 2018 (51)

More Years

Publications
  1. Blood (102)
  2. Haematologica (25)
  3. Clinical Lymphoma, Myeloma and Leukemia (21)
  4. Leukemia and Lymphoma (16)
  5. Biology of Blood and Marrow Transplantation (13)
  6. Blood Cancer Journal (10)

More Publications

Publishers
  1. American Society of Hematology (109)
  2. Elsevier Inc. (45)
  3. Nature Publishing Group (29)
  4. Ferrata Storti Foundation (25)
  5. Taylor & Francis Group (17)
  6. American Association for Cancer Research (15)

More Publishers

Results (336)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Patterns of infectious morbidity in patients with Waldenstrom's macroglobulinaemia/lymphoplasmacytic lymphoma: A population-based study
    Meeting Abstract

    Lund, S. H.; Hultcrantz, M.; Goldin, L.; Landgren, O.; Bjorkholm, M.; Turesson, I.; Kristinsson, S. Y.
    Blood (2014)

    Fulltext@MSK | Save
  • Increased bone marrow plasma cells at diagnosis predicts overall mortality in AL amyloidosis patients undergoing risk-adapted stem cell transplant
    Meeting Abstract

    Landry, C. A.; Smith, M.; Chou, J. F.; Devlin, S. M.; Hassoun, H.; Bello, C.; Landgren, O.; Giralt, S.; Comenzo, R. L.; Landau, H.
    Blood (2014)

    Fulltext@MSK | Save
  • Carfilzomib, lenalidomide, and dexamethasone in high-risk smoldering multiple myeloma: Final results from the NCI phase 2 pilot study
    Meeting Abstract

    Landgren, O.; Roschewski, M.; Mailankody, S.; Kwok, M.; Manasanch, E. E.; Bhutani, M.; Tageja, N.; Kazandjian, D.; Zingone, A.; Costello, R.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Minimal residual disease (MRD) testing in newly diagnosed multiple myeloma (MM) patients: A prospective head-to-head assessment of cell-based, molecular, and molecular-imaging modalities
    Meeting Abstract

    Korde, N.; Mailankody, S.; Roschewski, M.; Faham, M.; Kotwaliwale, C.; Moorhead, M.; Kwok, M. L.; Manasanch, E. E.; Bhutani, M.; Tageja, N.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Series of hairy cell leukemia patients with co-existent plasma cell disorders
    Meeting Abstract

    Korde, N.; Mailankody, S.; Arons, E.; Braylan, R. C.; Raffeld, M.; Maestri, E.; Yuan, C.; Stetler-Stevenson, M.; Landgren, O.; Maric, I.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Biomarker proteasome levels predict response to combination therapy with carfilzomib, lenalidomide, and dexamethasone in newly diagnosed multiple myeloma patients
    Meeting Abstract

    Korde, N.; Dosani, T.; Simakova, O.; Mailankody, S.; Costello, R.; Roschewski, M.; Yuan, C.; Stetler-Stevenson, M.; Figg, W. D.; Landgren, O.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Risk of arterial and venous thrombosis in 11,155 patients with myeloproliferative neoplasms and 44,620 matched controls; a population-based study
    Meeting Abstract

    Hultcrantz, M.; Andersson, T. M. L.; Landgren, O.; Derolf, A. R.; Dickman, P. W.; Bjorkholm, M.; Kristinsson, S. Y.
    Blood (2014)

    Fulltext@MSK | Save
  • Analysis of VDT-PACE utilization in multiple myeloma patients treated at MSKCC for relapsed disease or cytoreduction and stem cell mobilization after initial induction therapy
    Meeting Abstract

    Beyer, K.; Rosner, S.; Woo, K. M.; Devlin, S. M.; Landau, H.; Hassoun, H.; Lendvai, N.; Chung, D. J.; Adel, N. G.; Puto, M.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Upfront plerixafor plus G-CSF versus cyclophosphamide plus G-CSF for autologous stem cell mobilization in multiple myeloma patients: An update on cost analysis study at Memorial Sloan Kettering Cancer Center
    Meeting Abstract

    Afifi, S.; Adel, N. G.; Duck, E.; Devlin, S. M.; Landau, H.; Lendvai, N.; Lesokhin, A. M.; Chung, D. J.; Landgren, O.; Giralt, S. A.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • The road to treating smoldering multiple myeloma
    Conference Paper

    Korde, N.; Mailankody, S.; Landgren, O.
    Elsevier Inc. (2014)

    Fulltext@MSK | Save